from News Target, 6 April 2021
The U.S. Food and Drug Administration (FDA) and the Center for Science in the Public Interest (CSPI) are on a witch hunt against Dr. Joseph Mercola, who was threatened to stop writing about the health benefits of vitamin D in warding off respiratory illnesses like the Wuhan coronavirus (Covid-19).
Last summer, CSPI launched a social media campaign that aimed to put an immediate end to Mercola.com, the longtime health information website of Dr. Mercola. Not long after, the FDA issued Dr. Mercola a warning letter “to stop writing about nutritional products that can lower your risk of respiratory infections such as COVID-19.”
CSPI, in case you are unfamiliar with it, is a so-called “consumer advocacy group” bankrolled by the likes of Bill and Melinda Gates, the Rockefeller Foundation, the Rockefeller Family Fund, Bloomberg Philanthropies, and other deep state organizations advancing a global eugenics agenda.
CSPI is also partnered with Monsanto. Several years back, Gregory Jaffe, the group’s director of biotechnology, issued a statement declaring that mandatory labeling of genetically modified organisms (GMOs) should not happen because it would be “confusing” and “misleading” for consumers.
“CSPI rails against published science demonstrating certain nutrients can boost your immune function and help lower your risk of severe infection, saying it discourages mask-wearing, which has no published scientific evidence to back its universal use,” Dr. Mercola further explains.
“CSPI has a history of promoting industry science and propaganda, having supported artificial sweeteners, trans fats, GMOs, fake meat and the low-fat myth. They’ve also actively undermined transparency in labeling efforts.”
Being the fighter that he is, Dr. Mercola did not back down in the face of FDA aggression. In fact, he told the FDA off while asserting his First Amendment right to free speech, which he has been exercising for decades in the interest of promoting human health and longevity. … Continue reading at News Target >>>